Evidence map›Paper›PMID 24475174›Full record

ArticlePloS one2014

Cell-type specific four-component hydrogel.

Timo Aberle, Katrin Franke, Elke Rist, Karin Benz, Burkhard Schlosshauer

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Timo AberleNaturwissenschaftliches und Medizinisches Institut an der Universität Tübingen, Reutlingen, Germany.
Katrin FrankeNaturwissenschaftliches und Medizinisches Institut an der Universität Tübingen, Reutlingen, Germany.
Elke RistNaturwissenschaftliches und Medizinisches Institut an der Universität Tübingen, Reutlingen, Germany.
Karin BenzNaturwissenschaftliches und Medizinisches Institut an der Universität Tübingen, Reutlingen, Germany.
Burkhard SchlosshauerNaturwissenschaftliches und Medizinisches Institut an der Universität Tübingen, Reutlingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the field of regenerative medicine we aim to develop implant matrices for specific tissue needs. By combining two per se, cell-permissive gel systems with enzymatic crosslinkers (gelatin/transglutaminase and fibrinogen/thrombin) to generate a blend (technical term: quattroGel), an unexpected cell-selectivity evolved. QuattroGels were porous and formed cavities in the cell diameter range, possessed gelation kinetics in the minute range, viscoelastic properties and a mechanical strength appropriate for general cell adhesion, and restricted diffusion. Cell proliferation of endothelial cells, chondrocytes and fibroblasts was essentially unaffected. In contrast, on quattroGels neither endothelial cells formed vascular tubes nor did primary neurons extend neurites in significant amounts. Only chondrocytes differentiated properly as judged by collagen isoform expression. The biophysical quattroGel characteristics appeared to leave distinct cell processes such as mitosis unaffected and favored differentiation of sessile cells, but hampered differentiation of migratory cells. This cell-type selectivity is of interest e.g. during articular cartilage or invertebral disc repair, where pathological innervation and angiogenesis represent adverse events in tissue engineering.

Indexed as

Analysis of VarianceAnimalsBiomechanical PhenomenaBromodeoxyuridineCell Culture TechniquesCellsCells, CulturedCross-Linking ReagentsDiffusionDNA PrimersGene Expression ProfilingHumansHydrogel, Polyethylene Glycol DimethacrylateKineticsMiceOsmolar ConcentrationBromodeoxyuridineCross-Linking ReagentsDNA PrimersHydrogel, Polyethylene Glycol DimethacrylateViscoelastic Substances

Identifiers

PMID24475174
PMCPMC3903574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.